CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.
November 21st 2024
Aerobic exercise improved self-reported cognitive function in women undergoing chemotherapy for breast cancer but had no effect on objective cognitive function.
Experiencing a Breast Cancer Diagnosis After a Benign Tumor
March 6th 2018A complex fibroadenoma, even if it does not become cancerous, can correlate with a family history of breast cancer and an increased risk for cancer. Seeking more information from your doctors about how to proceed can offer peace of mind.
FDA Approves Frontline Verzenio for Advanced HR-Positive, HER2-Negative Breast Cancer
February 27th 2018The Food and Drug Administration (FDA) has approved Verzenio (abemaciclib) for use in combination with a hormonal therapy for initial treatment of postmenopausal women with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer.
Barbells for Boobs Strengthens the Fight Against Breast Cancer
February 12th 2018The mission of Barbells for Boobs is to mobilize and empower people to take action against breast cancer. The organization will help people – of all ages, and regardless of insurance status or type – to get screened by connecting them with resources in their area.
Patients Concerned as Humana Takes Herceptin Off Preferred Drug List in South Florida
January 30th 2018Until recently, Herceptin, which is used to treat patients with metastatic breast cancer, was fully covered under Humana’s South Florida Medicare Advantage plans. But, after taking it off the preferred drug list, patients will now be responsible for 20 percent of the drug’s cost, better aligning South Florida’s plans with Humana’s other Medicare Advantage plans.
Clinical Trial Scenarios Help to Appropriately Include Patients With Brain Metastases
January 23rd 2018Clinical trials designed to evaluate the use of anti-cancer drugs for the treatment of cancer typically exclude patients whose disease has spread to the brain or CNS for a number of reasons, including the misperception that they are poor clinical trial candidates.